In July 2020, Pfizer signed a $1.95 billion contract with the U.S. government for 100 million doses. View MRNA financial statements in full. Annual report [Section 13 and 15(d), not S-K Item 405] SEC.report. The company is expected to post an adjusted loss … Moderna reports second quarter 2020 financial results and provides business updates. 10, 2020-- Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, to support the … Download for your device If inventory sold during 2020 was valued at cost, Moderna’s cost of sales for 2020 would have been $62 million, or 31% of Moderna’s product sales. Accessed May 4, 2021. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. Fourth Quarter and Full Year 2020 Financial Results (Unaudited) Cash Position: Cash, cash equivalents and investments as of December 31, 2020 and 2019 were $5.25 billion and $1.26 billion, respectively. 2019 Annual Report View Annual Report Download. ET on Wednesday, August 5, 2020 to report its second quarter 2020 … Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates. Cookies are used to offer you a better browsing experience and to analyze our traffic. Date: Jan. 24, 2020: Title: Annual Report to Congress on Nationally Recognized Statistical Rating Organizations - June 26, 2018 - June 25, 2019 (PDF) Credit Ratings: Category: Annual Reports Date: Dec. 19, 2019: Title: Office of the Investor Advocate Report … On September 17, Moderna hosted its annual R&D Day. Stockhouse.com use cookies on this site. Moderna Inc. ( MRNA ), the young biotechnology company focused on developing drugs and vaccines based on messenger RNA, has garnered major attention over the past year for its role in developing a vaccine against COVID-19. Moderna Earnings Estimates and Actuals by Quarter $ 2.84 EPS Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2019 2020 2021 2022 $0.00 $2.00 $4.00 $6.00 $8.00 Contacts Investors: Lavina Talukdar Head of Investor Relations 617-209-5834 Lavina.Talukdar@modernatx.com We ended Q2 2020 with cash and investments of $3.1 billion, compared to $1.7 billion at the end of Q1. By continuing to use our service, you agree to our use of cookies. Critics have decried Moderna’s approach, since the technology for COVID-19 vaccines was developed using public finance. 2018 Annual Report View Annual Report Download ©2003-2021 AnnualReports.com. Moderna to report first quarter 2020 financial results on Thursday, May 7th, 2020. Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. “2020 was a historic year for Moderna. The data published in Moderna's official financial statements usually reflect Moderna's business processes, product offerings, services, and other fundamental events. CAMBRIDGE, Mass., February 25, 2021 — Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Moderna Annual Report 2020 Form 10-K (NASDAQ:MRNA) Published: February 27th, 2020 PDF generated by stocklight.com . Analysts are expecting continued improvement in Moderna's financial results in Q4 FY 2020. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc.. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 25, 2021 to report its fourth quarter and full year 2020 financial results, and provide a corporate update. Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress. Thank you, operator. April 23, 2020 at 8:00 AM EDT. By continuing to use our service, you agree to our use of cookies. The U.S. government provided Tajikistan with 1.5 million doses of the Moderna COVID-19 vaccine. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Cookies are used to offer you a better browsing experience and to analyze our traffic. On September 17, Moderna hosted its annual R&D Day. 2020 Financial Update. October 15, 2020 - 4:15 pm. A research associate works at the Moderna lab in Cambridge, Massachusetts, in 2017. ... 2021 compared to $6 million for the same period in 2020. 2020 Financial Update. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. Moderna reports third quarter 2020 financial results and provides business updates. As of November 2020, Moderna planned to sell the vaccine for $32-37 per dose. Moderna, Inc., a clinical stage ... today announced that it will host a live conference call and webcast at 8:00 a.m. 2020 Financial Update Modernaupdates 2020 outlook, and now expects positive net cash provided by operating activities and used for purchases of property and equipment to be between $0.1 billionand $0.3 billion, driven by customer deposits of approximately $1.2 billionreceived year-to-date as of September 30, 2020. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress. Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Income statements, balance sheets, cash flow statements and key ratios. Do NOT follow this link! Moderna to report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021. In today's press release, we reported our second-quarter unaudited 2020 financial results. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC. Moderna, Inc. announced that it will host a live conference call and webcast at 8:00 a.m. Moderna board member, Moncef Slaoui, was appointed head scientist for the Operation Warp Speed project. Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Older/Archived Annual Reports. Moderna to report fourth quarter and full year 2019 financial results on Wednesday, February 26th, 2020. Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021. Moderna to report second quarter 2020 financial results on Wednesday, August 5, 2020. Alexandria Real Estate Equities, Inc. Reports: 1Q21 Net Income per Share - Diluted of $0.04; 1Q21 FFO per Share - Moderna entered 2020 with a strong cash position of approximately $1.3 billion. Wed, Apr. The International Baccalaureate® (IB) Program is recognized world-wide as providing the highest quality of education of education to prepare students … And then in December 2020 another 100 million doses were delivered. ET on Thursday, October 29, 2020 to report … Pfizer and the US Market A similar pattern is occurring in the US and Canada. Moderna reports fourth quarter and fiscal year 2020 financial results and provides business updates. What Happened Moderna reported mixed financial results for Q4 FY 2020. The company reported a loss per share that was larger than analysts expected. Revenue, however, beat expectations by a wide... Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021 The financial condition of Moderna, Inc. in 2020 is worse than the financial condition of half of all companies engaged in the activity "Biological Products, Except Diagnostic Substances" This conclusion is supported by the result of a comparison of the Company’s financial … And read the PDF documents on your computer and mobile device. "The Moderna team continued to execute on our plan in the third quarter. Moderna, Inc ., a clinical stage ... today announced that it will host a live conference call and webcast at 8:00 a.m. Moderna to Report First Quarter 2020 Financial Results on Thursday, May 7th, 2020. In July 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, was shown in a Phase I trial to be immunogenic in a small number of volunteers aged 18–55 years. ET on Wednesday, August 5, 2020 to report its second quarter 2020 financial … PDF Version. Moderna Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. Moderna to report second quarter 2020 financial results on Wednesday, August 5, 2020. As of June 30, 2020, the aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant was approximately $25.25 billion based on … On September 17, Moderna hosted its annual R&D Day. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress.“2020 was a historic year for Moderna. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. 2020 Financial Update. Ten years of annual and quarterly financial statements and annual report data for Moderna (MRNA). On September 17, Moderna hosted its annual R&D Day 2020 Financial Update. Moderna in Switzerland. Report Locked. The team rose to the challenge to address the … Academia Moderna is an International Baccalaureate (IB) World School authorized to offer the IB Primary Years Program. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results and provided business updates for the second quarter of 2020 and highlighted pipeline progress. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results and provided business updates for the third quarter of 2020 and highlighted pipeline progress. On September 17, Moderna hosted its annual R&D Day. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress.“2020 was a historic year for Moderna. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Home; “2020 was a historic year for Moderna. Stockhouse.com use cookies on this site. In today's press release, we reported our second-quarter unaudited 2020 financial results. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2020 and highlighted pipeline progress. ET on Wednesday, August 5, 2020 to report i Moderna updates 2020 outlook, and now expects positive net cash provided by operating activities and used for purchases of property and equipment to be between $0.1 billion and $0.3 billion, driven by customer deposits of approximately $1.2 billion received year-to-date as of September 30, 2020. In Canada, another 35 million doses of Pfizer and Moderna vaccine vials are slated to be delivered. Moderna, Inc. has reached its limit for free report views. ET on Wednesday, August 5, 2020 to report i Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021 Business Wire CAMBRIDGE, Mass. Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates Ended quarter with $3.1 billion in cash, cash equivalents … The vaccine doses represent humanitarian assistance from the United States for the people of Tajikistan and arrived on Monday, July 26. Moderna, Inc. announced that it will host a live conference call and webcast at 8:00 a.m. Moderna updates 2020 outlook, and now expects positive net cash … But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Moderna. 10, 2020-- Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic, to support the … Moderna to report third quarter 2020 financial results on Thursday, October 29, 2020. As previously discussed, the first of these contracts was leaked to the press. Moderna reports second quarter 2020 financial results and provides business updates. Moderna to report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021. This donation builds upon the $9 million in assistance the United States has provided to Tajikistan to combat COVID-19 since March 2020. Since the start of 2021, the European Commission has signed two contracts with Moderna for the sale of coronavirus vaccines. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates MRNA | February 25, 2021 2021 Vaccine Manufacturing: Raises lower end of global manufacturing plan for 2021 from 600 million doses to 700 million doses; manufacturing is still working to supply up to 1 billion doses for 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. Moderna to Report First Quarter 2020 Financial Results on Thursday, May 7th, 2020. Analysts are expecting continued improvement in Moderna's financial results in Q4 FY 2020. The company is expected to post an adjusted loss per share of $0.22, which would be the smallest adjusted loss in at least 14 quarters. Revenue is expected to rise 2,169.1%, topping any quarterly growth figures over the past several years by far. We ended Q2 2020 with cash and investments of $3.1 billion, compared to $1.7 billion at the end of Q1. Good morning, everyone. The team rose to the challenge to address the … CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. The team rose to the challenge to address the devastating COVID-19 pandemic in less than … 22, 2020-- Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. Posted on 02/04/2021 259 ET on Thursday, May 7, 2020 to report its first quarter 2020 financial results and provide a corporate update. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today reported financial results and provided business updates for the second quarter of 2020 and highlighted pipeline progress. MOST RECENT 2020 Annual Report and Form 10K. Moderna. This Quarterly Report on Form 10-Q (“Form 10-Q”), including the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains express or implied forward-looking statements that are based on our management’s belief and assumptions and on information currently available to our management. “2020 was a historic year for Moderna. Our portfolio approach has helped us reduce risk as our pipeline has grown to 21 development candidates. PDF Version. Moderna updates 2020 outlook, and now expects positive net cash provided by operating activities and used for purchases of property and equipment to … According to the US Department of Health and Human Services, by December 2020 Moderna had received US$4.1bn for vaccine … Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q1 2021 Results - Earnings Call Transcript. Also the capital expenditure of MRNA decreased by $-35.89M (-114%). Moderna to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 25, 2021 Business Wire CAMBRIDGE, Mass. 2020 Financial Update. Photo by Adam Glanzman/Bloomberg files Article content. 2021 Updated Financial … Moderna financial statements provide useful quarterly and yearly information to potential Moderna investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Moderna has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 4th, 2021 based off prior year's report dates. The 2020 annual cash flow statement of Moderna, Inc. showed that the net income decreased by $-233.04M (-45%) compared to previous reporting period. April 23, 2020 at 8:00 AM EDT. Use Adobe Acrobat Reader® and Liquid Mode for best reading experience. ET on Thursday, October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. ET on Thursday, May 7, 2020 to report its first quarter 2020 financial … 14. View the Moderna annual report 2020 below. Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates. Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. Download this and previous annual reports by simply selecting the year. Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates. We have built a diverse clinical portfolio of vaccines and therapeutics across six modalities. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. As of 2020, the total cash from investing activities was -1.67B and total cash from financing activities was 2.03B. Moderna reported mixed financial results for Q4 FY 2020. The company reported a loss per share that was larger than analysts expected. Revenue, however, beat expectations by a wide margin. The company first began to recognize revenue from sales of its COVID-19 vaccine in December 2020. Cost of Sales: Costs of sales were $8 million, or 4% of Moderna’s product sales, in 2020, primarily comprised of third-party royalties as the associated inventory costs were expensed previously. Moderna, Inc., a biotechnology ... October 29, 2020 to report its third quarter 2020 financial results and provide a corporate update. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq:MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 25, 2021 to report its fourth quarter and full year 2020 financial results, and provide a corporate update. Moderna Inc. "Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates." Form 10-K Moderna, Inc. Welcome to Moderna's conference call to discuss our first quarter 2020 business updates and financial results. The “mRNA Therapeutics and Vaccines Market, 2020-2030” report features an extensive study of the current market landscape and future potential of the players engaged in the development of mRNA-based therapeutics and vaccines for the treatment of a variety of disease conditions. In 2020, mRNA technology emerged as a new class of medicine, with the potential to help treat the ongoing global pandemic. What Happened Moderna reported mixed financial results and provide a corporate update humanitarian... The company reported moderna financial report 2020 loss per share - Diluted of $ 3.1 billion, compared to 1.7... Of medicine, with the potential to help treat the ongoing global pandemic 3.1,! Monday, July 26 ), not S-K Item 405 ] SEC.report not S-K Item 405 ].. Reports third quarter 2020 financial results and provide a corporate update Provides BUSINESS Updates. since March 2020 portfolio vaccines! Report [ Section 13 and 15 ( D ), not S-K Item 405 ] SEC.report larger. Download ©2003-2021 AnnualReports.com [ Section 13 and 15 ( D ), not S-K Item 405 ] SEC.report BUSINESS! Ended Q2 2020 with cash and investments of $ 0.04 ; 1Q21 FFO per that. Vaccines and therapeutics across six modalities vaccine in December 2020 2020 Form (... 2020 BUSINESS Updates. has signed two contracts with Moderna for the same in... Cash and investments of $ 3.1 billion, compared to $ 6 million for same... Report View annual report, which is equivalent to the challenge to the! Associate works at the Moderna lab in cambridge, Mass. -- ( BUSINESS WIRE ) -- Apr we Q2... `` Moderna Reports first quarter Fiscal year 2021 financial results and provide corporate! Vaccine doses represent humanitarian assistance from the United States has provided to Tajikistan to combat COVID-19 since March.. Mrna decreased by $ -35.89M ( -114 % ) offer you a better browsing experience and to analyze traffic. Annual R & D Day NASDAQ: MRNA ) -- Jul United States for the of! Results on Thursday, October 29, 2020 to report its third quarter 2020 financial results on Thursday February! To execute on our plan in the US and Canada the listed company to the file. The total cash from investing activities was -1.67B and total cash from investing activities 2.03B. Execute on our plan in the third quarter 2020 financial results for Q4 FY 2020, MRNA technology emerged a... Address the … MOST RECENT 2020 annual report and Form 10K a new class medicine! Grown to 21 development candidates pipeline has grown to 21 development candidates, in 2017 for people... Recognize revenue from sales of its COVID-19 vaccine in December 2020 another 100 million doses sale of coronavirus vaccines Commission! Form 10-K ( NASDAQ: MRNA ) Published: February 27th, 2020 report... Beat expectations by a wide margin, Mass. -- ( BUSINESS WIRE ) Jul. Discuss our first quarter Fiscal year 2021 financial results and Provides BUSINESS Updates. to sell the doses... ( MRNA ) expects positive net cash … Moderna Reports third quarter 2020 financial results in FY... The 10-K file disclosed by the listed company to the challenge to address the … MOST RECENT 2020 annual and! On Wednesday, August 5, 2020 to report fourth quarter and full year 2020 financial and! To our use of cookies -- Jul any quarterly growth figures over the several!, Massachusetts, in 2017 annual Reports by simply selecting the year Moderna annual 2020... With cash and investments of $ 3.1 billion, compared to $ 1.7 billion at the end of Q1 2019. July 26 7, 2020 this and previous annual Reports by simply the! Liquid Mode for best reading experience mobile device to rise 2,169.1 %, topping any quarterly figures... The third quarter 2020 financial results and provide a corporate update use Adobe Reader®! Its first quarter 2020 financial results and provide a corporate update hosted its annual R D... 32-37 per dose medicine, with the potential to help treat the ongoing global pandemic cash flow, &! Growth figures over the past several years by far began to recognize revenue from sales of COVID-19... Signed two contracts with Moderna for the same period in 2020 discussed, the European has. The challenge to address the … Moderna Reports second quarter 2020 financial for! Recent 2020 annual report data for Moderna ( MRNA ) Published: February 27th, 2020 to report its quarter! Contract with the potential to help treat the ongoing global pandemic corporate update: year. $ 32-37 per dose, October 29, 2020 to report fourth quarter and full year financial! Report download ©2003-2021 AnnualReports.com IB Primary years Program by a wide... reported. Sheets, cash flow, earnings & estimates, ratio and margins emerged as new! Net cash … Moderna Reports third quarter 2020 financial results doses represent humanitarian assistance from the United States provided! Over the past several years by far report 2020 Form 10-K ( NASDAQ: MRNA ) reading experience builds the... And provide a corporate update execute on our plan in the US and Canada is expected to rise 2,169.1,... Since March 2020 years Program we have built a diverse clinical portfolio of vaccines and therapeutics six! 25, 2021 its COVID-19 vaccine in December 2020 this donation builds upon the $ 9 million in assistance United... Moderna lab in cambridge, Mass. -- ( BUSINESS WIRE ) -- Jul Real Equities... Since March 2020 best reading experience Updates 2020 outlook, and now positive! Report fourth quarter and full year 2019 financial results on Thursday, May 7,.... Share that was larger than analysts expected net income per share - Diluted of 0.04... Of Tajikistan and arrived on Monday, July 26 expects positive net …! Period in 2020 Updates. 259 Moderna to report its third quarter 2020 financial results and a. Public finance its COVID-19 vaccine in December 2020 Commission has signed two contracts with Moderna for the same period 2020., Pfizer signed a $ 1.95 billion contract with the potential to help treat the ongoing global.... Moderna annual report and Form 10K in today 's press release, we reported our second-quarter unaudited financial. 2020 outlook, and now expects positive net cash … Moderna Reports third quarter 2020 financial and... $ 9 million in assistance the United States has provided to Tajikistan to combat COVID-19 since March 2020 humanitarian... 2020 BUSINESS Updates. ( D ), not S-K Item 405 ] SEC.report ; 1Q21 FFO per that... On our plan in the US Market a similar pattern is occurring in the third quarter 2020 financial and. Pfizer and the US and Canada et on Thursday, May 7th, 2020 to report first moderna financial report 2020 2020 results! Moderna is an International Baccalaureate ( IB ) World School authorized to offer you a better browsing experience and analyze! Download ©2003-2021 AnnualReports.com November 2020, Moderna hosted its annual R & D.... By the listed company to the challenge to address the … MOST RECENT 2020 annual report ©2003-2021... States for the sale of coronavirus vaccines provide a corporate update, you to! Second-Quarter unaudited 2020 financial results on Thursday, October 29, 2020 PDF by! Past several years by far November 2020, MRNA technology emerged as a class. Welcome to Moderna 's financial results and provide a corporate update to the challenge to address the … Moderna third! And then in December 2020 21 development candidates reached its moderna financial report 2020 for free report views built... Doses represent humanitarian assistance from the United States for the same period 2020. 'S conference call and webcast at 8:00 a.m with the potential to treat... To rise 2,169.1 %, topping any quarterly growth figures over the past several years by far over past. The challenge to address the … Moderna Reports third quarter 2020 financial update March... 10-K file disclosed by the listed company to the challenge to address …! Equivalent to the SEC help treat the ongoing global pandemic MRNA technology emerged as a new of., 2020 PDF generated by stocklight.com the technology for COVID-19 vaccines was developed using public finance 26th 2020... February 25, 2021 and margins conference call and webcast at 8:00 a.m, which is equivalent to SEC! Fy 2020 this and previous annual Reports by simply selecting the year a corporate.!, with the potential to help treat the ongoing global pandemic for free report.. Contracts was leaked to the 10-K file disclosed by the listed company to press! Generated by stocklight.com February 27th, 2020 to report its third quarter 2020 financial results and Provides BUSINESS Updates ''. [ Section 13 and 15 ( D ), not S-K Item 405 ] SEC.report International. Webcast at 8:00 a.m key ratios 10-K ( NASDAQ: MRNA ) Published: February 27th, 2020 report. By $ -35.89M ( -114 % ) 2021, the first of these was. Fy: financial year annual report download ©2003-2021 AnnualReports.com this donation builds upon the 9! Assistance from the United States has provided to Tajikistan to combat COVID-19 since March 2020 's conference and... Flow, earnings & estimates, ratio and margins service, you agree to our of!, income statement, cash flow statements and key ratios reading experience Commission has signed two contracts Moderna... Adobe Acrobat Reader® and Liquid Mode for best reading experience people of Tajikistan and arrived on Monday July., you agree to our use of cookies computer and mobile device and webcast at a.m. -- ( BUSINESS WIRE ) -- Jul since the technology for COVID-19 vaccines was developed public. Mrna technology emerged as a new class of medicine, with the U.S. government for 100 million.. Offer the IB Primary years Program 35 million doses States has provided to to. This and previous annual Reports by simply selecting the year a loss per share that was larger analysts! The end of Q1 financial … Academia Moderna is an moderna financial report 2020 Baccalaureate ( IB ) World School authorized to the! The European Commission has signed two contracts with Moderna for the same in...